F079 Advancing Care, Inclusivity, and Advocacy in Dermatology
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This forum aims to highlight the importance of building health communities. It will also highlight considerations of the healthcare needs of underserved patient populations. This session is intended for a broad audience, where we hope to engage in valuable discussion and consider a variety of thought and experiences as they pertain to these topics. The session will feature current leaders in this work and will present opportunities for participants to learn more about and support this work as it relates to personal relationships, mentorship, sponsorship, research, and education.
LEARNING OBJECTIVES
Discuss strategies to building healthier communities
Discuss steps to improve care of underserved patient populations
SCHEDULE
1:00 PM
State of the Specialty
Rebecca Vasquez, MD, FAAD
1:10 PM
AAD’s Efforts to Address Health Disparities
Loren Krueger, MD, FAAD
1:20 PM
Resident selection processes and signaling
Vinod Nambudiri, MD, MBA, FAAD
1:35 PM
Care for asylum seekers and forensic dermatology
Herbert B Castillo Valladares, MD, FAAD
1:50 PM
Considerations for inclusion, advocacy, and care for sexual and gender diverse populations in dermatology
Klint Peebles, MD, FAAD
2:05 PM
Care for individuals with disabilities
Haley Naik, MD, FAAD
2:20 PM
AI in Dermatology
Jenna C Lester, MD, FAAD
2:35 PM
Hot topics panel
Victoria Holloway Barbosa, MD, FAAD, Sacharitha Bowers, MD, FAAD, Kanade Shinkai, MD, PhD, FAAD
SPEAKERS
Victoria Holloway Barbosa, MD, FAAD
Sacharitha Bowers, MD, FAAD
Herbert B Castillo Valladares, MD, FAAD
Loren Krueger, MD, FAAD
Jenna C Lester, MD, FAAD
Janiene Luke, MD, FAAD
Haley Naik, MD, FAAD
Vinod Nambudiri, MD, MBA, FAAD
Klint Peebles, MD, FAAD
Kanade Shinkai, MD, PhD, FAAD
Rebecca Vasquez, MD, FAAD
SPEAKER DISCLOSURES
Victoria Holloway Barbosa, MD, FAAD
Eli Lilly and Company – Advisory Board(Fees), Consultant(Fees); L'Oreal USA Inc. – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees), Other(Grants/Research Funding); Vichy Laboratoires – Advisory Board(Fees);
Sacharitha Bowers, MD, FAAD
No financial relationships exist with ineligible companies.
Herbert B Castillo Valladares, MD, FAAD
No financial relationships exist with ineligible companies.
Loren Krueger, MD, FAAD
No financial relationships exist with ineligible companies.
Jenna C Lester, MD, FAAD
Animate Biosciences – Advisory Board(Stock Options); Google – Consultant(Fees); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); L'Oreal – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Advisory Board(Fees);
Janiene Luke, MD, FAAD
Arcutis Biotherapeutics – Speaker(Honoraria); Eli Lilly – Speaker(Honoraria); Sanofi/Regeneron – Speaker(Honoraria);
Haley Naik, MD, FAAD
23andMe – Consultant(Honoraria); AbbVie – Consultant(Honoraria), Other(Grants/Research Funding); Aristea Therapeutics, Inc. – Consultant(Honoraria); Boehringer Ingelheim – Advisory Board(Honoraria); Dava Oncology – Consultant(Honoraria); Johnson and Johnson – Consultant(Honoraria); Medscape – Consultant (1099 relationship)(Fees); Nimbus Therapeutics – Consultant(Honoraria); Novartis – Consultant (1099 relationship)(Fees); Radera Biotherapeutics, Inc. – Stockholder Private Company(Stock Options); Radera, Inc. – Stockholder Private Company(Stock Options); Sonoma Biotherapeutics – Consultant (1099 relationship)(Fees); UCB – Consultant (1099 relationship)(Fees);
Vinod Nambudiri, MD, MBA, FAAD
McGraw-Hill Companies – Other(Other Financial Benefit); Merck & Co., Inc – Other(Other Financial Benefit);
Klint Peebles, MD, FAAD
Kaiser Permanente – Employee(Salary);
Kanade Shinkai, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Rebecca Vasquez, MD, FAAD
Incyte – Consultant (1099 relationship)(Honoraria);